A recently described method measuring the peak early‐phase enhancement ratio (PEER) between tumour and renal cortex on computed tomography (CT) examinations reported up to 100% accuracy in differentiating CD117 positive benign oncocytomas from chRCC.9 The gene discussed is KIT; the disease is oncocytic neoplasm.